A company formed as a spinout from Cancer Research UK-funded science at The Institute of Cancer Research, London, has been publicly launched, with $32.5 million in f...

AbbVie and Genmab have signed a pact to jointly develop and commercialise three of the latter's early-stage investigational bispecific antibody product candidates, a...

The COVID-19 pandemic has tested pharma's supply chain and spawned several drug shortages. Now, with mental health suffering, antidepressant Zoloft and its generics ...

Sanofi has a big job ahead as it goes after Johnson & Johnson blockbuster Darzalex in the multiple myeloma field. But the French drugmaker's contender, Sarclisa,...

Bristol Myers Squibb notched a big win with its recent approval of multiple sclerosis drug Zeposia, a Celgene pipeline pickup with blockbuster as...

Novavax is racing against some of the world’s biggest pharmaceutical companies in its COVID-19 vaccine effort, and the biotech has now brought on a partner ...

Sanofi and Regeneron rejiggered their longstanding antibody partnership based on underwhelming sales of key drugs in the past. But one thing that won't change is the...

Bristol Myers Squibb’s Opdivo and Yervoy only just won their first approval in previously untreated metastatic non-small cell lung cancer, but the pair is already ma...

n its pursuit of a COVID-19 vaccine, Novavax bagged a major cash infusion earlier this month thanks to a nearly $400 million grant from a global epidemic response fu...